Aquestive Therapeutics, Inc. (AQST) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $328K. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 15, 2026 | Barber Daniel President and CEO | −$120,488 | 25,000 | −4% | Yes | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 9, 2026 | Korczynski Sherry Chief Commercial Officer | $22,488 | 26,250 | 0% | Yes | |
|
|
||||||
| Sept. 10, 2026 filed Sept. 9, 2026 | Boyd Peter E. Chief People Officer | $2,201 | 4,586 | — | No | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 8, 2026 | Barber Daniel President and CEO | $88,073 | 183,486 | — | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 3, 2026 | Jung Cassie Chief Operating Officer | $4,404 | 9,174 | — | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free